Home » Topics » Regulatory » Patents

Patents
RSS

Pharmakea discloses ENPP2 inhibitors

Sep. 29, 2016

Vectus Biosystems patents vasodilating agents

Sep. 29, 2016

MFMER reports NADH-ubiquinone oxidoreductase inhibitors

Sep. 28, 2016

Shuttle Pharmaceuticals presents HDAC inhibitors and erine-protein kinase ATM activators

Sep. 28, 2016

University of California develops anti-alphavbeta1 integrin inhibitors

Sep. 28, 2016

Genentech and Hoffmann-La Roche describe DLK inhibitors

Sep. 28, 2016

Hoffmann-La Roche discloses TLR8 agonists

Sep. 28, 2016

Pharmakea patents LOX2 inhibitors

Sep. 28, 2016

LTT Bio-Pharma presents muscarinic M3 receptor antagonists

Sep. 27, 2016

BioMarin Pharmaceutical develops CGS inhibitors

Sep. 27, 2016

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...